Last updated on May 2017

Immune Monitoring Protocol in Men With Prostate Cancer Enrolled in a Clinical Trial of Sipuleucel-T


Brief description of study

The purpose of this study is to evaluate the immune response induced by sipuleucel-T (Provenge®).

Detailed Study Description

Subjects will receive sipuleucel-T, and potentially other medications, as part of the clinical trial in which they are concurrently enrolled. For this study, cellular and humoral immune responses will be assessed. No additional study treatments will be conducted beyond what is required for the subject's concurrent clinical trial.

Clinical Study Identifier: NCT01727154

Find a site near you

Start Over

First Urology, PSC

Jeffersonville, IN United States
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.